SC Pharmaceuticals
0026938.790.00% ( 0.00 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: SC Pharmaceuticals(002693) the Revenue is 48.44 M (+32.08%);the EBIT is 3.352 M (+129.7%);the EPS is 0.0083 (+134.3%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.05B32.08%
----
----
EBIT
0.00B129.65%
----
----
EPS
0.0083134.30%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf